Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2021 | Angel | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BIOCHING CAPITAL | — | Angel |